SHL Telemedicine Ltd. (SHLT)
USD 2.05
(0.99%)
USD 2.05
(0.99%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 34.26 Million USD | -17.7% |
| 2022 | 31.93 Million USD | 30.14% |
| 2021 | 24.54 Million USD | 24.59% |
| 2020 | 19.69 Million USD | 11.0% |
| 2019 | 17.74 Million USD | -3.41% |
| 2018 | 18.37 Million USD | 0.35% |
| 2017 | 18.31 Million USD | -16.98% |
| 2016 | 22.05 Million USD | -6.42% |
| 2015 | 23.56 Million USD | 11.62% |
| 2014 | 21.11 Million USD | -1.03% |
| 2013 | 21.33 Million USD | 6.89% |
| 2012 | 19.95 Million USD | -12.5% |
| 2011 | 22.81 Million USD | -16.41% |
| 2010 | 27.28 Million USD | -1.55% |
| 2009 | 27.71 Million USD | 0.72% |
| 2008 | 27.52 Million USD | -35.54% |
| 2007 | 42.69 Million USD | 31.78% |
| 2006 | 32.39 Million USD | -26.66% |
| 2005 | 44.17 Million USD | -4.7% |
| 2004 | 46.35 Million USD | 6.35% |
| 2003 | 43.58 Million USD | 27.84% |
| 2002 | 34.09 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.5 Million USD | -0.13% |
| 2024 Q2 | 8.5 Million USD | 0.0% |
| 2023 Q1 | 8.61 Million USD | -46.29% |
| 2023 Q3 | 6.87 Million USD | -58.39% |
| 2023 Q2 | 16.52 Million USD | 91.9% |
| 2023 Q4 | 8.52 Million USD | 23.86% |
| 2023 FY | 26.28 Million USD | -17.7% |
| 2022 Q2 | 15.75 Million USD | 98.04% |
| 2022 Q3 | 4.68 Million USD | -70.26% |
| 2022 FY | 31.93 Million USD | 30.14% |
| 2022 Q4 | 16.03 Million USD | 242.4% |
| 2022 Q1 | 7.95 Million USD | -40.84% |
| 2021 FY | 24.54 Million USD | 24.59% |
| 2021 Q2 | 5.51 Million USD | 0.0% |
| 2021 Q1 | 5.51 Million USD | -49.6% |
| 2021 Q3 | 13.44 Million USD | 143.91% |
| 2021 Q4 | 13.44 Million USD | 0.0% |
| 2020 Q2 | 8.9 Million USD | 88.64% |
| 2020 Q3 | 5.41 Million USD | -39.16% |
| 2020 FY | 19.69 Million USD | 11.0% |
| 2020 Q4 | 10.93 Million USD | 101.96% |
| 2020 Q1 | 4.71 Million USD | -48.28% |
| 2019 Q2 | 8.68 Million USD | 97.82% |
| 2019 Q1 | 4.38 Million USD | -54.04% |
| 2019 Q3 | 4.82 Million USD | -44.47% |
| 2019 FY | 17.74 Million USD | -3.41% |
| 2019 Q4 | 9.12 Million USD | 89.23% |
| 2018 Q4 | 9.54 Million USD | 95.58% |
| 2018 Q2 | 8.75 Million USD | 99.21% |
| 2018 Q1 | 4.39 Million USD | -12.28% |
| 2018 FY | 18.37 Million USD | 0.35% |
| 2018 Q3 | 4.88 Million USD | -44.23% |
| 2017 Q1 | 2.78 Million USD | -49.85% |
| 2017 FY | 18.31 Million USD | -16.98% |
| 2017 Q4 | 5.01 Million USD | 0.0% |
| 2017 Q3 | 5.01 Million USD | 80.14% |
| 2017 Q2 | 2.78 Million USD | 0.0% |
| 2016 Q3 | 5.54 Million USD | -0.72% |
| 2016 Q1 | 5.58 Million USD | -52.43% |
| 2016 Q2 | 5.58 Million USD | 0.0% |
| 2016 FY | 22.05 Million USD | -6.42% |
| 2016 Q4 | 5.54 Million USD | 0.0% |
| 2015 FY | 23.56 Million USD | 11.62% |
| 2015 Q4 | 11.74 Million USD | 0.0% |
| 2015 Q3 | 11.74 Million USD | 93.45% |
| 2015 Q2 | 6.07 Million USD | 57.44% |
| 2015 Q1 | 3.85 Million USD | -12.2% |
| 2014 FY | 21.11 Million USD | -1.03% |
| 2014 Q1 | 5.61 Million USD | -42.4% |
| 2014 Q2 | 5.69 Million USD | 1.46% |
| 2014 Q3 | 5.41 Million USD | -4.92% |
| 2014 Q4 | 4.39 Million USD | -18.89% |
| 2013 FY | 21.33 Million USD | 6.89% |
| 2013 Q4 | 9.74 Million USD | 111.5% |
| 2013 Q3 | 4.6 Million USD | 32.08% |
| 2013 Q2 | 3.48 Million USD | -0.2% |
| 2013 Q1 | 3.49 Million USD | -37.32% |
| 2012 Q3 | 4.73 Million USD | 8.67% |
| 2012 FY | 19.95 Million USD | -12.5% |
| 2012 Q4 | 5.57 Million USD | 17.69% |
| 2012 Q1 | 4.81 Million USD | -7.91% |
| 2012 Q2 | 4.36 Million USD | -9.51% |
| 2011 FY | 22.81 Million USD | -16.41% |
| 2011 Q4 | 5.23 Million USD | -0.93% |
| 2011 Q3 | 5.28 Million USD | -13.92% |
| 2011 Q1 | 6.16 Million USD | 5.59% |
| 2011 Q2 | 6.13 Million USD | -0.44% |
| 2010 Q1 | 6.4 Million USD | -20.61% |
| 2010 Q4 | 5.83 Million USD | -21.71% |
| 2010 Q3 | 7.45 Million USD | 13.61% |
| 2010 FY | 27.28 Million USD | -1.55% |
| 2010 Q2 | 6.56 Million USD | 2.4% |
| 2009 Q4 | 8.07 Million USD | 12.57% |
| 2009 FY | 27.71 Million USD | 0.72% |
| 2009 Q3 | 7.16 Million USD | 13.31% |
| 2009 Q2 | 6.32 Million USD | 13.51% |
| 2009 Q1 | 5.57 Million USD | 0.0% |
| 2008 Q2 | 6.77 Million USD | 0.0% |
| 2008 FY | 27.52 Million USD | -35.54% |
| 2007 FY | 42.69 Million USD | 31.78% |
| 2006 FY | 32.39 Million USD | -26.66% |
| 2005 FY | 44.17 Million USD | -4.7% |
| 2004 FY | 46.35 Million USD | 6.35% |
| 2003 FY | 43.58 Million USD | 27.84% |
| 2002 FY | 34.09 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Omnicell, Inc. | 534.79 Million USD | 93.593% |
| Renalytix Plc | 29.04 Million USD | -17.995% |
| Schrödinger, Inc. | 318.14 Million USD | 89.229% |
| Simulations Plus, Inc. | 37.02 Million USD | 7.437% |
| SOPHiA GENETICS SA | 117.73 Million USD | 70.896% |
| Streamline Health Solutions, Inc. | 31.19 Million USD | -9.865% |
| BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 97.337% |
| CareCloud, Inc. | 93.35 Million USD | 63.295% |
| HealthEquity, Inc. | 401.74 Million USD | 91.47% |
| iCoreConnect Inc. | 15.12 Million USD | -126.572% |
| Inovalon Holdings, Inc. | 427.99 Million USD | 91.994% |
| Ontrak, Inc. | 29.47 Million USD | -16.258% |
| Minerva Surgical, Inc. | 58.14 Million USD | 41.062% |
| Nutex Health, Inc. | 66.54 Million USD | 48.508% |
| OneMedNet Corporation | 8.24 Million USD | -315.541% |
| Progyny, Inc. | 176.61 Million USD | 80.598% |
| Augmedix, Inc. | 40.3 Million USD | 14.981% |
| CareCloud, Inc. | 93.35 Million USD | 63.295% |
| GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.375% |
| Sharecare, Inc. | 225.97 Million USD | 84.836% |
| Aclarion, Inc. | 4.87 Million USD | -602.818% |
| CareMax, Inc. | 670.05 Million USD | 94.886% |
| Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | -531.379% |
| Forian Inc. | 20.59 Million USD | -66.35% |
| Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -531.379% |
| HeartBeam, Inc. | 15.31 Million USD | -123.763% |
| GeneDx Holdings Corp. | 224.28 Million USD | 84.722% |
| SCWorx Corp. | 2.71 Million USD | -1159.937% |
| Definitive Healthcare Corp. | 546.47 Million USD | 93.729% |
| 10x Genomics, Inc. | 674.94 Million USD | 94.923% |
| Zhongchao Inc. | 13.92 Million USD | -146.127% |
| Accolade, Inc. | 306.51 Million USD | 88.82% |
| MSP Recovery, Inc. | 565.43 Million USD | 93.94% |
| R1 RCM Inc. | 336.6 Million USD | 89.82% |
| Spok Holdings, Inc. | 90.97 Million USD | 62.335% |
| Privia Health Group, Inc. | 134.31 Million USD | 74.488% |
| EUDA Health Holdings Limited | 4.8 Million USD | -613.431% |
| TruBridge, Inc. | 206.17 Million USD | 83.379% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 97.337% |
| Sharecare, Inc. | 225.97 Million USD | 84.836% |
| Health Catalyst, Inc. | 258.73 Million USD | 86.756% |
| GoodRx Holdings, Inc. | 710.34 Million USD | 95.176% |
| Premier, Inc. | 683.65 Million USD | 94.988% |
| HealthStream, Inc. | 168.02 Million USD | 79.606% |
| Certara, Inc. | 254.08 Million USD | 86.514% |
| GeneDx Holdings Corp. | 224.28 Million USD | 84.722% |
| Ontrak, Inc. | 29.47 Million USD | -16.258% |
| CareCloud, Inc. | 93.35 Million USD | 63.295% |
| EUDA Health Holdings Limited | 4.8 Million USD | -613.431% |
| HeartBeam, Inc. | 15.31 Million USD | -123.763% |
| Mangoceuticals, Inc. | 9.65 Million USD | -255.084% |
| CareMax, Inc. | 670.05 Million USD | 94.886% |
| Healthcare Triangle, Inc. | 18.12 Million USD | -89.059% |
| National Research Corporation | 52.52 Million USD | 34.754% |
| Aclarion, Inc. | 4.87 Million USD | -602.818% |
| OptimizeRx Corporation | 69.3 Million USD | 50.554% |